rs12828016

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018979.4(WNK1):​c.5424G>T​(p.Met1808Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.388 in 1,612,936 control chromosomes in the GnomAD database, including 123,394 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1808V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.41 ( 13066 hom., cov: 32)
Exomes 𝑓: 0.39 ( 110328 hom. )

Consequence

WNK1
NM_018979.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.446

Publications

64 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.491094E-5).
BP6
Variant 12-889199-G-T is Benign according to our data. Variant chr12-889199-G-T is described in ClinVar as [Benign]. Clinvar id is 261073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.499 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.6180G>T p.Met2060Ile missense_variant Exon 21 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.5424G>T p.Met1808Ile missense_variant Exon 21 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.6180G>T p.Met2060Ile missense_variant Exon 21 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.5424G>T p.Met1808Ile missense_variant Exon 21 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.407
AC:
61765
AN:
151874
Hom.:
13054
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.505
Gnomad AMI
AF:
0.268
Gnomad AMR
AF:
0.342
Gnomad ASJ
AF:
0.414
Gnomad EAS
AF:
0.286
Gnomad SAS
AF:
0.462
Gnomad FIN
AF:
0.283
Gnomad MID
AF:
0.468
Gnomad NFE
AF:
0.386
Gnomad OTH
AF:
0.429
GnomAD2 exomes
AF:
0.370
AC:
92947
AN:
251292
AF XY:
0.375
show subpopulations
Gnomad AFR exome
AF:
0.513
Gnomad AMR exome
AF:
0.289
Gnomad ASJ exome
AF:
0.401
Gnomad EAS exome
AF:
0.279
Gnomad FIN exome
AF:
0.285
Gnomad NFE exome
AF:
0.379
Gnomad OTH exome
AF:
0.398
GnomAD4 exome
AF:
0.386
AC:
563448
AN:
1460944
Hom.:
110328
Cov.:
39
AF XY:
0.388
AC XY:
281819
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.511
AC:
17090
AN:
33452
American (AMR)
AF:
0.294
AC:
13167
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.409
AC:
10691
AN:
26116
East Asian (EAS)
AF:
0.323
AC:
12820
AN:
39672
South Asian (SAS)
AF:
0.446
AC:
38452
AN:
86236
European-Finnish (FIN)
AF:
0.290
AC:
15472
AN:
53384
Middle Eastern (MID)
AF:
0.490
AC:
2824
AN:
5768
European-Non Finnish (NFE)
AF:
0.386
AC:
429418
AN:
1111228
Other (OTH)
AF:
0.390
AC:
23514
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
18399
36798
55198
73597
91996
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13530
27060
40590
54120
67650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.407
AC:
61814
AN:
151992
Hom.:
13066
Cov.:
32
AF XY:
0.401
AC XY:
29825
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.505
AC:
20910
AN:
41412
American (AMR)
AF:
0.341
AC:
5215
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.414
AC:
1436
AN:
3466
East Asian (EAS)
AF:
0.286
AC:
1478
AN:
5168
South Asian (SAS)
AF:
0.461
AC:
2225
AN:
4826
European-Finnish (FIN)
AF:
0.283
AC:
2989
AN:
10566
Middle Eastern (MID)
AF:
0.473
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
0.387
AC:
26269
AN:
67966
Other (OTH)
AF:
0.432
AC:
909
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1869
3739
5608
7478
9347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
61363
Bravo
AF:
0.412
TwinsUK
AF:
0.394
AC:
1462
ALSPAC
AF:
0.384
AC:
1480
ESP6500AA
AF:
0.510
AC:
2248
ESP6500EA
AF:
0.391
AC:
3363
ExAC
AF:
0.377
AC:
45722
Asia WGS
AF:
0.412
AC:
1433
AN:
3478
EpiCase
AF:
0.408
EpiControl
AF:
0.404

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Neuropathy, hereditary sensory and autonomic, type 2A Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 12, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism type 2C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
13
DANN
Benign
0.89
DEOGEN2
Benign
0.060
T;.;T;.;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.080
N
LIST_S2
Benign
0.077
T;T;T;T;T
MetaRNN
Benign
0.000025
T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
-0.69
.;.;N;.;.
PhyloP100
-0.45
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.19
N;.;N;.;N
REVEL
Benign
0.011
Sift
Benign
0.21
T;.;T;.;T
Sift4G
Benign
0.43
T;.;T;T;T
Polyphen
0.0
B;.;B;.;.
Vest4
0.086
MutPred
0.28
.;.;Loss of catalytic residue at M1808 (P = 0.0215);.;.;
MPC
0.13
ClinPred
0.0011
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.033
gMVP
0.19
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12828016; hg19: chr12-998365; COSMIC: COSV60032006; COSMIC: COSV60032006; API